Viridian Therapeutics, Inc.\DE short interest in 2020
In 2020, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 1.41% of shares outstanding on 15 Jan 2020 to 2.59% on 15 Oct 2020, a change of +1.18 percentage points. The year's high was 3.56% on 31 Jul 2020 and its low 0.39% on 31 Mar 2020, averaging 1.85% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.31 days on 15 Sep 2020. Full history: Viridian Therapeutics, Inc.\DE.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 1.41% (15 Jan 2020)
- End of year
- 2.59% (15 Oct 2020)
- Change
- +1.18 pp
- High
- 3.56% (31 Jul 2020)
- Low
- 0.39% (31 Mar 2020)
- Average
- 1.85%
- Highest days to cover
- 3.31 (15 Sep 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 1.41% | 1.00 | |
| 31 Jan 2020 | 3.28% | 1.00 | |
| 28 Feb 2020 | 1.42% | 1.00 | |
| 13 Mar 2020 | 0.55% | 1.00 | results (8-K), 10-K filed |
| 31 Mar 2020 | 0.39% | 1.00 | |
| 15 Apr 2020 | 0.39% | 1.00 | |
| 30 Apr 2020 | 0.62% | 1.00 | |
| 15 May 2020 | 0.65% | 1.00 | results (8-K), 10-Q filed |
| 29 May 2020 | 0.61% | 1.00 | |
| 15 Jun 2020 | 0.92% | 1.00 | |
| 30 Jun 2020 | 2.20% | 1.00 | |
| 15 Jul 2020 | 2.35% | 1.30 | |
| 31 Jul 2020 | 3.56% | 1.00 | |
| 14 Aug 2020 | 3.39% | 1.65 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 3.15% | 2.16 | |
| 15 Sep 2020 | 3.10% | 3.31 | |
| 30 Sep 2020 | 2.77% | 2.47 | |
| 15 Oct 2020 | 2.59% | 1.16 |
See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.